Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amar Puttanna

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|May 23, 2014
Recurrent cardiac tamponade: an initial presentation of lung adenocarcinomaAditi Kumar, Amar Puttanna
BMJ Case Reports|October 29, 2014
Amiodarone-induced thyrotoxicosis: type 1 or type 2?Ahsan Khan, Amar Puttanna, Diana Raskauskiene
Clinical Medicine Insights. Gastroenterology|June 23, 2016
Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance ManagementAditi Kumar, Daniel Wheatley, Amar Puttanna
The Open Respiratory Medicine Journal|February 13, 2015
Systemic effects of inhaled corticosteroids: an overviewDhruti Pandya, Amar Puttanna, Viswanatha Balagopal
BMJ Case Reports|July 30, 2013
Addison's disease and its associationsAmar Puttanna, Alana Rosaleen Cunningham, Philip Dainty
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 8, 2021
Diabetes and Frailty: An Expert Consensus Statement on the Management of Older Adults with Type 2 DiabetesW David Strain, Su Down, Pam Brown, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 11, 2022
Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in Patients with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the UKRory J McCrimmon, Karen Palmer, Abdul Jabbar Omar Alsaleh, et al.
Postgraduate Medical Journal|December 26, 2019
Changing perceptions: a multicentre survey of final-year medical students' and junior doctors' perceptions of diabetes and endocrinologyAmar Puttanna, Megan L Byrne, Susannah N Eyre-Brook, et al.
BMJ Open Diabetes Research & Care|May 29, 2025
Healthcare utilization and costs in adults with type 2 diabetes treated with first or second-generation basal insulins in EnglandNeil Holden, Onyinye Diribe, Karen Palmer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|May 23, 2014
Recurrent cardiac tamponade: an initial presentation of lung adenocarcinomaAditi Kumar, Amar Puttanna
BMJ Case Reports|October 29, 2014
Amiodarone-induced thyrotoxicosis: type 1 or type 2?Ahsan Khan, Amar Puttanna, Diana Raskauskiene
Clinical Medicine Insights. Gastroenterology|June 23, 2016
Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance ManagementAditi Kumar, Daniel Wheatley, Amar Puttanna
The Open Respiratory Medicine Journal|February 13, 2015
Systemic effects of inhaled corticosteroids: an overviewDhruti Pandya, Amar Puttanna, Viswanatha Balagopal
BMJ Case Reports|July 30, 2013
Addison's disease and its associationsAmar Puttanna, Alana Rosaleen Cunningham, Philip Dainty
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 8, 2021
Diabetes and Frailty: An Expert Consensus Statement on the Management of Older Adults with Type 2 DiabetesW David Strain, Su Down, Pam Brown, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 11, 2022
Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in Patients with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the UKRory J McCrimmon, Karen Palmer, Abdul Jabbar Omar Alsaleh, et al.
Postgraduate Medical Journal|December 26, 2019
Changing perceptions: a multicentre survey of final-year medical students' and junior doctors' perceptions of diabetes and endocrinologyAmar Puttanna, Megan L Byrne, Susannah N Eyre-Brook, et al.
BMJ Open Diabetes Research & Care|May 29, 2025
Healthcare utilization and costs in adults with type 2 diabetes treated with first or second-generation basal insulins in EnglandNeil Holden, Onyinye Diribe, Karen Palmer, et al.
Pageof 1